Christopher Schaber

Chief Executive Officer at SOLIGENIX, INC.

Net worth: 5 801 $ as of 2026-07-30

59 year

64 connections

Health Technology

Consumer Services

Commercial Services

Profile

Dr. Christopher J.
Schaber is a Member-Corporate Council at The National Organization for Rare Disorders, Inc., a Member-Corporate Council at American Society for Blood & Marrow Transplantation and a Chairman, President & Chief Executive Officer at Soligenix, Inc. He is on the Board of Directors at Simphotek, Inc., Alliance for Biosecurity and BioNJ, Inc. Dr. Schaber was previously employed as a Chief Operating Officer & Executive Vice President by Discovery Laboratories, Inc., a Chief Operating Officer & Executive Vice President by Discovery Laboratories, Inc., a VP-Regulatory Compliance & Drug Development by Acute Therapeutics, Inc., and a Worldwide Director-Regulatory Affairs & Operations by Ohmeda PPD, Inc. He also served on the board at BioSecurity Technologies, Inc. He received his undergraduate degree from McDaniel College, a graduate degree from Temple University School of Pharmacy and a doctorate degree from Union Institute & University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SOLIGENIX, INC. 0.07%	2026-07-19	15,511 ( 0.07% )	5 801 $	2026-07-30

Christopher Schaber active positions

Companies	Position	Start
SOLIGENIX, INC.	Chief Executive Officer	2006-07-31
The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services	Corporate Officer/Principal	2010-08-16
American Society for Blood & Marrow Transplantation American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs.	Corporate Officer/Principal	2009-06-30
Alliance for Biosecurity	Director/Board Member	2014-09-30
BioNJ, Inc. BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey	Director/Board Member	-
Simphotek, Inc. Simphotek, Inc. Medical SpecialtiesHealth Technology Develops dosimetry devices for cancer treatments	Director/Board Member	2018-05-31

All active positions of Christopher Schaber

Former positions of Christopher Schaber

Companies	Position	End
WINDTREE THERAPEUTICS, INC.	Chief Operating Officer	2005-12-31
Discovery Laboratories, Inc. Discovery Laboratories, Inc. Part of Windtree Therapeutics, Inc., Discovery Laboratories, Inc. is an American company that specializes in the development of drug products for patients with respiratory disease. The company, now known as Windtree Technologies, Inc., was established in 1992 and is based in Warrington, PA. The company's main products include Surfaxin, a synthetic, peptide-containing surfactant that is delivered to the lung using capillary aerosol-generating technology, and Aerosurf, a drug-device combination designed to prevent respiratory distress syndrome in premature infants. Additionally, the company offers Afectair devices, disposable aerosol airway connectors.	Chief Operating Officer	2005-12-31
Acute Therapeutics, Inc.	Founder	1997-12-31
░░░░░░ ░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Christopher Schaber's experience

Training of Christopher Schaber

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Schaber's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Soligenix, Inc. Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products	Health Technology
Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets	Health Technology
BioSecurity Technologies, Inc. BioSecurity Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Acquires intellectual properties	Commercial Services
Simphotek, Inc. Simphotek, Inc. Medical SpecialtiesHealth Technology Develops dosimetry devices for cancer treatments	Health Technology
McDaniel College McDaniel College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Union Institute & University Union Institute & University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acute Therapeutics, Inc.
The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services	Health Services
American Society for Blood & Marrow Transplantation American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs.
Ohmeda PPD, Inc.
BioNJ, Inc. BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey	Commercial Services
Alliance for Biosecurity
Temple University School of Pharmacy Temple University School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Discovery Laboratories, Inc. Discovery Laboratories, Inc. Part of Windtree Therapeutics, Inc., Discovery Laboratories, Inc. is an American company that specializes in the development of drug products for patients with respiratory disease. The company, now known as Windtree Technologies, Inc., was established in 1992 and is based in Warrington, PA. The company's main products include Surfaxin, a synthetic, peptide-containing surfactant that is delivered to the lung using capillary aerosol-generating technology, and Aerosurf, a drug-device combination designed to prevent respiratory distress syndrome in premature infants. Additionally, the company offers Afectair devices, disposable aerosol airway connectors.